09/20/2024 | Press release | Distributed by Public on 09/19/2024 20:03
- -
FRONTEO, Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Growth)
FRONTEO is pleased to announce that an article advertisement titled "AI can hunt for hidden clues to new drugs in published papers" about AI drug discovery using the natural language processing technology of FRONTEO's in-house developed specialized AI "KIBIT" has been published on the Nature website.
We are developing an innovative AI drug discovery support service (Drug Discovery AI Factory) that uses our unique AI technology to discover unknown information from known information, predicts unreported genes with high disease relevance, and provides target genes for drug discovery and the underlying hypotheses. We are also collaborating with Springer Nature on the analysis of papers published in the company's journals for this service.
[Article URL]
AI can hunt for hidden clues to new drugs in published papers
https://www.nature.com/articles/d42473-024-00248-3